Board Committee Changes

RNS Number : 8698W

Centamin PLC

24 April 2019

 

For immediate release		24 April 2019

Centamin plc ("Centamin" or "the Company")

(LSE:CEY, TSX:CEE)

Board Committee Changes

In accordance with the UKLA Listing Rule 9.6.11R (3), Centamin is pleased to announce the following Board committee changes:

·      Dr Sally Eyre, Independent Non-Executive Director, will join the Remuneration Committee, with immediate effect.

·      Mark Bankes, Independent Non-Executive Director, will join the Nomination Committee and step down from the Remuneration Committee, with immediate effect.

The Remuneration Committee now comprises of G. Edward Haslam (Chair), Mark Arnesen and Dr Sally Eyre.

The Nomination Committee now comprises of G. Edward Haslam (Chair), Mark Arnesen, Alison Baker and Mark Bankes.

Full Board Committee details including composition can be found on our website: https://www.centamin.com/investors/corporate-governance.  

This announcement contains regulated information.

Enquiries

For further information, please visit the website www.centamin.com or contact:

Centamin plc Andrew Pardey, Chief Executive Officer Alexandra Carse, Investor Relations [e-mail]

Buchanan Bobby Morse Chris Judd [e-mail]

_____________________________________________________________________________________________________

 

END

 

 

MSCDGGDSRUDBGCX